+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Plasma Protein Therapeutics Market Size, Share & Trends Analysis Report By Product (Albumin, Immunoglobulin, Plasma-derived Factor VIII), By Application (Hemophilia, PID, ITP), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 86 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 5893191
Description Jump to:
The global plasma protein therapeutics market size is expected to reach USD 45.1 billion by 2030, registering a CAGR of 6.1% from 2023 to 2030. The growth can be attributed to high prevalence of bleeding and other rare disorders, rising investment in R&D, and increasing use of plasma-derived products in neurology and other therapeutic indications.

Plasma-derived proteins are primarily used as replacement therapies to treat chronic, rare diseases. Patients that rely on these medications require regular injections or infusions throughout their lives. While there are more than 250 products derived from plasma, key players generally rely on Immunoglobulin (IG), albumin, and factor VIII to drive sales and profitability.

Over the past decade, the plasma protein therapeutics market has grown lucratively with immunoglobulin capturing the major market share. Demand for plasma derived-products is driven by rising disease prevalence, geriatric population, and improved access to drugs in emerging markets. Approvals of new plasma-derived therapies are anticipated to further fuel the demand. Developing countries such as China and Brazil offer new investment avenues to the global market giants.

Plasma Protein Therapeutics Market Report Highlights

  • Demand for immunoglobulin is expected to continue rising owing to prevalence of primary immunodeficiencies, usage in new indications, and ease of administration
  • Non-plasma based recombinant therapies are likely to compete with plasma-derived products in the factor VIII market
  • The primary immunodeficiency diseases segment captured the largest market share of 26.5% in 2022 and is expected to exhibit substantial growth with a CAGR of 6.2% through the forecast period
  • Asia Pacific accounted for the largest market share of 35.7% in 2022 and is expected to exhibit the fastest CAGR of 8.6% over the forecast period fueled by increasing healthcare expenditure, presence of a large number of patients. improved ratio of patients suffering from disease and patients receiving treatment, low-cost production of drugs, and improvement in diagnostic technology.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Plasma Protein Therapeutics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Plasma Protein Therapeutics market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Plasma Protein Therapeutics market: Product Estimates & Trend Analysis
4.1. Plasma Protein Therapeutics market: Key Takeaways
4.2. Plasma Protein Therapeutics market: Movement & Market Share Analysis, 2022 & 2030
4.3. Albumin
4.3.1. Albumin market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Immunoglobulin
4.4.1. Immunoglobulin market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Plasma-derived Factor VIII
4.5.1. Plasma-derived factor VIII market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Others
4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Plasma Protein Therapeutics market: Application Estimates & Trend Analysis
5.1. Plasma Protein Therapeutics market: Key Takeaways
5.2. Plasma Protein Therapeutics market: Movement & Market Share Analysis, 2022 & 2030
5.3. Hemophilia
5.3.1. Hemophilia market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Primary Immunodeficiency Disorder (PID)
5.4.1. Primary immunodeficiency disorder (PIDD) market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Idiopathic Thrombocytopenic Purpura (ITP)
5.5.1. Idiopathic thrombocytopenic purpura (ITP) market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Plasma Protein Therapeutics market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Plasma Protein Therapeutics market by Region: Key Takeaways
6.3. North America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.6. Denmark
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.7. Sweden
6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.8. Norway
6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. South Africa
6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. CSL
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Grifols, S.A.
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Takeda
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Octapharma AG
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Biotest AG
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Kedrion S.p.A
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 3 North America plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 4 North America plasma protein therapeutics market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 6 U.S. plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 7 Canada plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 8 Canada plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 9 Europe plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 10 Europe plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 11 Europe plasma protein therapeutics market, by region, 2018 - 2030 (USD Million)
Table 12 Germany plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 13 Germany plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 14 UK plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 15 UK plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 16 France plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 17 France plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 18 Italy plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 19 Italy plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 20 Spain plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 21 Spain plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 22 Denmark plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 23 Denmark plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 24 Sweden plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 25 Sweden plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 26 Norway plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 27 Norway plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 28 Asia Pacific plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 29 Asia Pacific plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 30 Asia Pacific plasma protein therapeutics market, by region, 2018 - 2030 (USD Million)
Table 31 Japan plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 32 Japan plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 33 China plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 34 China plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 35 India plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 36 India plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 37 Australia plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 38 Australia plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 39 Thailand plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 40 Thailand plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 41 South Korea plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 42 South Korea plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 43 Latin America plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 44 Latin America plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 45 Latin America plasma protein therapeutics market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 47 Brazil plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 48 Mexico plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 49 Mexico plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 50 Argentina plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 51 Argentina plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa plasma protein therapeutics market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 56 South Africa plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 59 UAE plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 60 UAE plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
Table 61 Kuwait plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
Table 62 Kuwait plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Plasma protein therapeutics: Market outlook
Fig. 9 Plasma protein therapeutics: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Plasma protein therapeutics market driver impact
Fig. 15 Plasma protein therapeutics market restraint impact
Fig. 16 Plasma protein therapeutics market strategic initiatives analysis
Fig. 17 Plasma protein therapeutics market: Product movement analysis
Fig. 18 Plasma protein therapeutics market: Product outlook and key takeaways
Fig. 19 Albumin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Immunoglobulin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Factor VIII market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Plasma protein therapeutics market: Application movement analysis
Fig. 23 Plasma protein therapeutics market: Application outlook and key takeaways
Fig. 24 Hemophilia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Primary immunodeficiency disorder (PIDD) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Idiopathic thrombocytopenic purpura (ITP) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Global plasma protein therapeutics market: Regional movement analysis
Fig. 29 Global plasma protein therapeutics market: Regional outlook and key takeaways
Fig. 30 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • CSL
  • Grifols, S.A.
  • Takeda
  • Octapharma AG
  • Biotest AG
  • Kedrion S.p.A

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages86
PublishedSeptember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 28.2 Billion
Forecasted Market Value ( USD ) by 2030 $ 45.1 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned6

Related Topics

Related Reports

Plasma Protein Therapeutics Market by Product, Application - Global Forecast 2025-2030 - Product Image

Plasma Protein Therapeutics Market by Product, Application - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Plasma Protein Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Plasma Protein Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Recombinant Protein Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type (Growth Hormones, Interferons, Vaccines, Immunostimulating Agents, Others), By Source, By Indication, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Recombinant Protein Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type (Growth Hormones, Interferons, Vaccines, Immunostimulating Agents, Others), By Source, By Indication, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 173 Pages
  • Global
From
Plasma Protein Therapeutics - Global Strategic Business Report - Product Image

Plasma Protein Therapeutics - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Plasma Protein Therapeutics Global Market Report 2024 - Product Image

Plasma Protein Therapeutics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.